Correlation of adverse effects and antibody responses following homologous and heterologous COVID-19 prime-boost vaccinations

Correlation of adverse effects and antibody responses following homologous and heterologous COVID-19 prime-boost vaccinations

Show other versions (1)

Bibliographic Details
Main Authors:	Aristine Cheng, Wang-Huei Sheng, Shan-Chwen Chang
Format:	Article
Language:	English
Published:	Elsevier 2023-05-01
Series:	Journal of the Formosan Medical Association
Online Access:	http://www.sciencedirect.com/science/article/pii/S0929664622004788

Similar Items

Correlation of adverse effects and antibody responses following homologous and heterologous COVID19 prime-boost vaccinations
by: Aristine Cheng, et al.
Published: (2023-05-01)

Adverse effects and antibody responses following homologous and heterologous COVID19 prime-boost vaccinations
by: Amnuay Kleebayoon, et al.
Published: (2023-05-01)

Response to comments on “Serological response and safety of heterologous ChAdOx1-nCoV-19/mRNA-1273 prime-boost vaccination”
by: Wang-Huei Sheng, et al.
Published: (2023-01-01)

Heterologous Prime-Boost Vaccination with Commercial FMD Vaccines Elicits a Broader Immune Response than Homologous Prime-Boost Vaccination in Pigs
by: Jaejo Kim, et al.
Published: (2023-02-01)

Immunogenicity and Safety of Homologous and Heterologous Prime–Boost Immunization with COVID-19 Vaccine: Systematic Review and Meta-Analysis
by: Haoyue Cheng, et al.
Published: (2022-05-01)

Heterologous Prime-Boost Vaccination with Inactivated Influenza Viruses Induces More Effective Cross-Protection than Homologous Repeat Vaccination
by: Noopur Bhatnagar, et al.
Published: (2023-07-01)

Protection of laying chickens against the Canadian DMV/1639 infectious bronchitis virus infection through priming with heterologous live vaccine and boosting with heterologous or homologous inactivated vaccine
by: Mohamed S.H. Hassan, et al.
Published: (2024-01-01)

Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data
by: Shaw, RH, et al.
Published: (2021)

Heterologous prime-boost vaccination against COVID-19: is it safe and reliable?
by: Om Prakash Choudhary, et al.
Published: (2021-12-01)

Reactogenicity and immunogenicity of heterologous prime-boost immunization with COVID-19 vaccine
by: Thuy Trang Nguyen, et al.
Published: (2022-03-01)

Immune response of heterologous versus homologous prime-boost regimens with adenoviral vectored and mRNA COVID-19 vaccines in immunocompromised patients
by: Chang Chu, et al.
Published: (2023-06-01)

Comparison of homologous and heterologous prime-boost vaccine approaches using Modified Vaccinia Ankara and soluble protein to induce neutralizing antibodies by the human cytomegalovirus pentamer complex in mice.
by: Flavia Chiuppesi, et al.
Published: (2017-01-01)

Cross-Reactivity Conferred by Homologous and Heterologous Prime-Boost A/H5 Influenza Vaccination Strategies in Humans: A Literature Review
by: Adinda Kok, et al.
Published: (2021-12-01)

DNA-based vaccines for malaria: a heterologous prime-boost immunisation strategy.
by: Hill, A, et al.
Published: (2000)

Heterologous prime-boost vaccination protects against EBV antigen-expressing lymphomas.
by: Rühl, J, et al.
Published: (2019)

Developing a personalized heterologous prime boost vaccination strategy for tumor therapy
by: Ramirez-Valdez, RA
Published: (2021)

Assessment of an LSDV-Vectored Vaccine for Heterologous Prime-Boost Immunizations against HIV
by: Ros Chapman, et al.
Published: (2021-11-01)

Is heterologous prime-boost COVID-19 vaccination a concern or an opportunity for Ethiopia?
by: Tesfaye Gelanew, et al.
Published: (2023-01-01)

Exploring heterologous prime-boost vaccination approaches to enhance influenza control in pigs
by: Chong Li, et al.
Published: (2020-07-01)

An Immunogenicity Report for the Comparison between Heterologous and Homologous Prime-Boost Schedules with ChAdOx1-S and BNT162b2 Vaccines
by: Alexandre Vallée, et al.
Published: (2021-08-01)

Immunogenicity and safety of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine: a systematic review
by: Jingjing Lv, et al.
Published: (2022-05-01)

Reactogenicity after heterologous and homologous COVID-19 prime-boost vaccination regimens: descriptive interim results of a comparative observational cohort study
by: Lisette Warkentin, et al.
Published: (2022-05-01)

Investigation of Adverse Events Experienced by Healthcare Workers following Immunization with Homologous or Heterologous COVID-19 Booster Vaccinations
by: Yunhua Wei, et al.
Published: (2022-11-01)

Heterologous Prime-Boost HIV-1 Vaccination Regimens in Pre-Clinical and Clinical Trials
by: Julia L. Hurwitz, et al.
Published: (2010-02-01)

Heterologous booster vaccination with CoronaVac following prime vaccination with mRNA vaccine
by: Yun Shan Goh, et al.
Published: (2022-01-01)

In-depth analysis of T cell immunity and antibody responses in heterologous prime-boost-boost vaccine regimens against SARS-CoV-2 and Omicron variant
by: Natalie Heinen, et al.
Published: (2022-12-01)

Homologous versus Heterologous prime-boost COVID-19 Vaccination in autologous hematopoietic stem cell transplantation recipients: a blinded randomized controlled trial
by: Leyla Sharifi Aliabadi, et al.
Published: (2023-08-01)

Immunogenicity and Protective Efficacy of Brugia malayi Heavy Chain Myosin as Homologous DNA, Protein and Heterologous DNA/Protein Prime Boost Vaccine in Rodent Model.
by: Jyoti Gupta, et al.
Published: (2015-01-01)

The Effects of Heterologous Immunization with Prime-Boost COVID-19 Vaccination against SARS-CoV-2
by: Tzu-Chuan Ho, et al.
Published: (2021-10-01)

Immunogenicity of a Heterologous Prime-Boost COVID-19 Vaccination with mRNA and Inactivated Virus Vaccines Compared with Homologous Vaccination Strategy against SARS-CoV-2 Variants
by: Ruiqi Zhang, et al.
Published: (2022-01-01)

Homologous and heterologous prime boost vaccinations with distinct variants of Plasmodium vivax circumsporozoite protein (CSP) protects mice against transgenic PB/PV sporozoite challenge
by: Freitas, E, et al.
Published: (2017)

Homologous and Heterologous Prime-Boost Vaccination: Impact on Clinical Severity of SARS-CoV-2 Omicron Infection among Hospitalized COVID-19 Patients in Belgium
by: Marjan Meurisse, et al.
Published: (2023-02-01)

Complete protective immunity against blood-stage malaria induced by heterologous prime-boost vaccination
by: Draper, S, et al.
Published: (2005)

Intravenous heterologous prime-boost vaccination activates innate and adaptive immunity to promote tumor regression
by: Ramirez-Valdez, RA, et al.
Published: (2023)

Intravenous heterologous prime-boost vaccination activates innate and adaptive immunity to promote tumor regression
by: Ramiro A. Ramirez-Valdez, et al.
Published: (2023-06-01)

Heterologous prime-boost: breaking the protective immune response bottleneck of COVID-19 vaccine candidates
by: Qian He, et al.
Published: (2021-01-01)

Heterologous prime-boost vaccination with H3N2 influenza viruses of swine favors cross-clade antibody responses and protection
by: Kristien Van Reeth, et al.
Published: (2017-04-01)

Vaccination of chimpanzees with a multicomponent DNA-protein prime-boost regimen provides an enhanced recovery following heterologous HCV challenge.
by: Heeney, J, et al.
Published: (2001)

Comparing Heterologous and Homologous COVID-19 Vaccination: A Longitudinal Study of Antibody Decay
by: Chiara Orlandi, et al.
Published: (2023-05-01)

Immunogenicity and safety of heterologous versus homologous prime-boost schedules with inactivated and adenoviral vectored SARS-CoV-2 vaccines – A prospective multi-center study
by: Pawat Phuensan, et al.
Published: (2024-01-01)